Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Hospital-acquired infections (HAIs) such as pneumonia (ventilator-associated pneumonia [VAP]), bloodstream infection (BSI), urinary tract infection (UTI), and surgical site infection (SSI) have long been recognized as main problems affecting the overall quality of health care. Infection surveillance solutions, however, has been identified as a significant way to offer quality outcome indicators and detect key measures in order to reduce the burden of HAIs.
Rapid growth in the regions healthcare industry, increasing number of private hospitals, growing foreign direct investment, ongoing government initiatives and investment in the healthcare and healthcare IT industry, continuing research and development in the medical technology, and increasing hospital-acquired infections are major factors that could expand the growth of the market across the APAC region. In addition, rising number of infection surveillance program and projects in countries such as India, China and Japan is further boosting the market growth.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the infection surveillance solutions market. In addition, complete analysis of changes on infection surveillance solutions market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. Increasing number of hospitals and clinical laboratories for the diagnosis and the detection of the COVID-19 patient is improving the growth of infection surveillance solutions market. High-throughput technologies are being leveraged by a growing number of hospitals to prevent and control healthcare associated as well as COVID-19 infection spread effectively and rapidly on a wide scale.
The study analyses Asia Pacific infection surveillance solutions market based on product, end user and country.
Based on product, the Asia Pacific infection surveillance solutions market segmented into software and services segment. The software segment dominated the market in 2021 and is likely to witness rapid growth during the forecast period. The software segment is further sub-segmented into on-premise and web-based. Moreover, major services such as product support & maintenance services, training & consulting services and implementation services are analyzed in the market. Increasing demand for product support & maintenance services as it provide remote monitoring to maximize the system uptime is escalating the market growth. Moreover, these services offers customer support staff which are available 24/7 to address the issues or needs that may rise while using platform or software.
Major end users of Asia Pacific infection surveillance solutions market are hospitals, long-term care facilities, others. Hospitals is expected to gain major market share during the forecast period (2019-2028). The hospitals segment include sub-segments such as large hospitals, medium-sized hospitals and small hospitals. Furthermore, increasing elderly population, developing hospital healthcare facilities, and growing number of hospital admissions are ultimately creating more risk for spread of healthcare associated infections across hospital thereby increasing demand for infection surveillance solutions. However, long-term care facilities segment is anticipated to account for second largest share in the market during the projected timeframe. Long term facilities segment include sub-segments such as homecare agencies & hospices, nursing homes and assisted living facilities.
Country wise, the study is comprised of the key countries such as China, India, Japan and rest of Asia Pacific. China held the largest market share of Asia Pacific infection surveillance solutions market and is likely to dominate the market over the estimated time frame. Major growth factors such as increasing population of the country, rising number of hospitals, growing awareness regarding several preventative measures against COVID-19, and rising introduction of several infection surveillance systems for COVID-19 surveillance are accredited to the market growth.
The major key players of market includes Becton Dickson & Company (United States), Baxter International Inc (United States), Premier Inc (United States), Wolters Kluwer N.V (Netherlands), Gojo Industries, Inc (United States), RL Solutions (United States), Truven Health Analytics (An IBM Company) (United States), DEB Group Ltd (United Kingdom), Hygreen, Inc (United States), Vigilanz Corporation (United States), Cerner Corporation (United States), Epic Systems Corporation (United States), Vecna Technologies (United States), Emerald Health Information System (Canada), Medexter Healthcare (Austria), and PeraHealth Inc (United States) among others.
February 2021: Becton, Dickinson and Company announced collaboration with Scanwell Health for at-home rapid test for COVID-19.
October 2020: RLDatix, the global provider of intelligent patient safety solutions, acquired Verge Health, the recognized best-in-class credentialing software provider. This acquisition joins two companies in the governance, risk, and compliance healthcare software market and dramatically accelerated an essential shift from a reactive approach to risk management to one rooted in safety and prevention.
September 2018: Wolters Kluwer N.V launched the clinical surveillance solution Sentri7. This solution gives hospital tools and resources to stay in front of new challenges and battle the anti-biotic resistant bacteria.
The study analyses Asia Pacific infection surveillance solutions market based on product, end user, and country. Based on product, the Asia Pacific infection surveillance solutions market segmented into software and services segment. The software segment is likely to dominate the market over the forecast period. Increased adoption of infection surveillance software solutions in end use industries owing to its several benefits is attributed to the market growth. Major end users of Asia Pacific infection surveillance solutions market are hospitals, long-term care facilities, others. The hospitals segment is likely to register fastest growth in years to come owing to the increasing number of hospital admissions every year. Country wise, the study is comprised of the key countries such as China, India, Japan and rest of Asia Pacific.
Why to buy this report:
